Matches in Wikidata for { <http://www.wikidata.org/entity/Q66039799> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q66039799 description "assaig clínic" @default.
- Q66039799 description "clinical trial" @default.
- Q66039799 description "clinical trial" @default.
- Q66039799 description "clinical trial" @default.
- Q66039799 description "clinical trial" @default.
- Q66039799 description "ensaio clínico" @default.
- Q66039799 description "ensayo clínico" @default.
- Q66039799 description "ensayu clínicu" @default.
- Q66039799 description "essai clinique" @default.
- Q66039799 description "klinisch onderzoek" @default.
- Q66039799 description "клінічне випробування" @default.
- Q66039799 description "կլինիկական փորձարկում" @default.
- Q66039799 name "Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance" @default.
- Q66039799 name "Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance" @default.
- Q66039799 type Item @default.
- Q66039799 label "Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance" @default.
- Q66039799 label "Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance" @default.
- Q66039799 prefLabel "Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance" @default.
- Q66039799 prefLabel "Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance" @default.
- Q66039799 P1132 Q66039799-FBAE7402-EDE7-4682-924C-F5B02BB04F12 @default.
- Q66039799 P1476 Q66039799-01C6CEF2-0C92-4F8E-8D66-DAC81147C270 @default.
- Q66039799 P17 Q66039799-8AF58150-E1FA-4A04-A981-BCA6D65BE761 @default.
- Q66039799 P2899 Q66039799-C6C37EA5-29AF-428D-8C35-E467514D5F44 @default.
- Q66039799 P3098 Q66039799-DEF3A116-5614-4733-9E21-2567CAD2758A @default.
- Q66039799 P31 Q66039799-33953A04-2A69-4E8A-A922-64B4AA7CD4B1 @default.
- Q66039799 P4135 Q66039799-C62BC3A7-9A23-40D2-9305-56ECA9BB9D75 @default.
- Q66039799 P582 Q66039799-20F7BD96-D70B-4FCB-94BC-D835FFAA1435 @default.
- Q66039799 P6099 Q66039799-5E505108-5F74-4A12-8D75-D9ABC5861783 @default.
- Q66039799 P6153 Q66039799-76BEEB19-7678-4AA8-AA13-749671741EB9 @default.
- Q66039799 P6153 Q66039799-ACFB5B72-B868-435D-82F9-127D5587ABFF @default.
- Q66039799 P8363 Q66039799-209D9CA4-A701-4260-A91E-4C1DFCDF43D1 @default.
- Q66039799 P1132 "+118" @default.
- Q66039799 P1476 "A Phase II, Randomized, Open-Label Study Comparing Fixed-Dose Versus Concentration-Adjusted Lopinavir/Ritonavir Therapy in HIV-Infected Subjects on Salvage Therapy" @default.
- Q66039799 P17 Q30 @default.
- Q66039799 P2899 "+18" @default.
- Q66039799 P3098 "NCT00046033" @default.
- Q66039799 P31 Q30612 @default.
- Q66039799 P4135 "+70" @default.
- Q66039799 P582 "2003-03-01T00:00:00Z" @default.
- Q66039799 P6099 Q42824440 @default.
- Q66039799 P6153 Q235034 @default.
- Q66039799 P6153 Q49210 @default.
- Q66039799 P8363 Q78089383 @default.